Synfacts 2022; 18(06): 0689
DOI: 10.1055/s-0041-1738362
Chemistry in Medicine and Biology

First Asymmetric Synthesis of (+)-Thienamycin

Rezensent(en):
Dirk Trauner
,
Matthew DiCairano
Salzmann TN, *, Ratcliffe RW, Christensen BG, Bouffard FA. Merck Sharp & Dohm Research Laboratories, Rahway, USA
A Stereocontrolled Synthesis of (+)-Thienamycin.

J. Am. Chem. Soc. 1980;
102: 6161-6163
 

Significance

Thienamycin is a highly potent carbapenem antibiotic that demonstrates excellent activity against both Gram-positive and Gram-negative bacteria. It retains activity in the presence of β-lactamase enzymes and operates by inhibiting peptidoglycan biosynthesis. Because it decomposes when exposed to water, a more stable analogue (imipenem) was developed by Merck. In 1980, Salzmann and co-workers reported the first asymmetric total synthesis of thienamycin.


#

Comment

Starting from dibenzyl aspartate, a protection followed by cyclization afforded the desired azetidinone. To set the stereochemistry at C8, an acylation with N-acetylimidazole followed by reduction with K-Selectride was used. Key to the synthesis was a highly efficient carbene N–H insertion to form the sterically hindered bicyclic core of thienamycin. Finally, to complete the synthesis, a vinyl phosphate was displaced by F and a global deprotection gave thienamycin.


#
#

Publikationsverlauf

Artikel online veröffentlicht:
17. Mai 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany